Immunic investor relations
WitrynaWednesday, June 16, 2024 10:00 AM EDT. Eyenovia Inc. First Quarter 2024 Earnings Call. Wednesday, May 12, 2024 4:30 PM EDT. Eyenovia Inc. Fourth Quarter 2024 Earnings Call. Thursday, March 25, 2024 4:30 PM EDT. 33rd Annual Roth Conference. Monday, March 15 - Wednesday, March 17, 2024. WitrynaImmunic is a clinical-stage biopharmaceutical company with a pipeline of selective oral immunology therapies focused on treating chronic inflammatory and autoimmune …
Immunic investor relations
Did you know?
Witryna14 mar 2024 · Seed-Investment des HTGF: Münchner Startup oculai schließt 2,5 Mio. € Seed-Runde zur KI-gestützten Prozesserfassung auf Baustellen ab ... Parcellab, Cobrainer, Quantum Systems, Casavi, Riskmethods, Tubulis, Catalym, Immunic, Sirion und viele weitere. ... Stefanie Grüter, Partner Communications & Relations T.: +49 … WitrynaM.A. Business Management Student, Investor Relations and PR at Immunic Therapeutics Metropolregion München. 95 Follower:innen …
Witryna1 wrz 2024 · Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies focused on treating chronic inflammatory and autoimmune ... Witryna3 lis 2024 · Immunic expressly disclaims all liability in respect to actions taken or not taken based on any or all the contents of this press release. Contact Information Immunic, Inc. Jessica Breu Head of Investor Relations and Communications +49 89 2080 477 09 [email protected]
Witryna28 lip 2024 · Q1 2024 Athenex Inc. Earnings Conference Call. Monday, March 01, 2024 8:00 am EST. Q4 and Full Year 2024 Athenex, Inc. Earnings Conference Call. Monday, January 11, 2024 8:40 am EST. ATNX at 39th Annual J.P. Morgan Healthcare Conference. Wednesday, December 09, 2024 5:00 pm EST. WitrynaInvestor updates. Past IR events View all events. Investors. 2024 Credit Suisse Global Healthcare Conference. Read more. Investors. ... Investor relations team contacts. Genentech. Genentech has been delivering on the promise of biotechnology for over 35 years. Discover more. Contact. Locations.
Witryna5 sty 2024 · Investor Relations. Investor/Media Home; Press Releases; Events & Presentations; Analyst Coverage; Stock Information; SEC Filings; Corporate Governance; Investors/Media FAQs - Landos - Investor Tools. Print Page; RSS Feeds; Email Alerts; Landos Biopharma, Inc. PO Box 11239 Blacksburg, VA 24062. …
Witryna10 paź 2024 · Immunic, Inc. Jessica Breu Head of Investor Relations and Communications +49 89 2080 477 09 [email protected] US IR Contact Rx … r banknotesWitryna13 kwi 2024 · Immunic Inc (NASDAQ:IMUX) CEO Dr. Daniel Vitt speaks to Proactive following the release of data from the maintenance phase of its phase 2b CALDOSE-1 trial of lead asset vidofludimus calcium (IMU-838) in patients with moderate-to-severe ulcerative colitis (UC). Vitt describes it as "wonderful data" that came as a "positive … r bank of indiaWitryna14 lip 2024 · NEW YORK, July 14, 2024 /PRNewswire/ -- Immunic, Inc. (the "Company") (Nasdaq: IMUX ), a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies ... rbank credit card application statusWitryna3 mar 2024 · We disclaim any obligation to supplement or update the information in these press releases. Year. 2024. March 27, 2024. Incyte Announces Japanese Approval of Pemazyre® (pemigatinib) for the Treatment of Patients with Myeloid/Lymphoid Neoplasms (MLNs) March 23, 2024. Incyte Provides Regulatory Update on Ruxolitinib … sims 2 pets gamecube isoWitryna13 kwi 2024 · Immunic Inc (NASDAQ:IMUX) CEO Dr. Daniel Vitt speaks to Proactive following the release of data from the maintenance phase of its phase 2b CALDOSE … sims 2 pets gamecube romWitryna14 kwi 2024 · Immunic Inc. (NASDAQ: IMUX)’s stock price has soared by 10.14 in relation to previous closing price of 1.38. Nevertheless, the company has seen a loss of -1.94% in its stock price over the last five trading days. According a new report published by BloombergNEF on investment in the energy ... sims 2 peppermint and gingerWitryna3 lis 2024 · Immunic, Inc. Jessica Breu Head of Investor Relations and Communications +49 89 2080 477 09 [email protected]. US IR Contact Rx … r banks atherton